Get the Stockscreener App
103.23
0.19%
-0.20
After Hours:
103.23
Exact Sciences Corp Stock (EXAS) Forecast
The Exact Sciences Corp (EXAS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $108.69, representing a +5.29% increase from the current price of $103.23. The highest analyst price target is $123.77, and the lowest is $93.61.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EXAS Price Target
Average 93.64
(-9.29% Downside)
Is Exact Sciences Corp (EXAS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 73.34 | Sell |
| STOCH(9,6) | 86.57 | Sell |
| STOCHRSI(14) | 46.49 | Neutral |
| MACD(12,26) | 0.7882 | Sell |
| ADX(14) | 57.06 | Buy |
| William %R | -21.75 | Neutral |
| CCI(14) | 119.80 | Buy |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
102.88
Buy
|
102.98
Buy
|
| MA20 |
102.62
Buy
|
102.57
Buy
|
| MA50 |
102.02
Buy
|
98.21
Buy
|
| MA100 |
84.84
Buy
|
88.04
Buy
|
| MA200 |
68.12
Buy
|
76.07
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, EXAS could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 3 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on EXAS, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 73.34 indicates that EXAS is overbought. This suggests that EXAS price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 86.57 indicates that EXAS is oversold. This means that EXAS price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 46.49 indicates that EXAS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 57.06 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 119.8 indicates that EXAS is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term EXAS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Exact Sciences Corp financial reports and earnings history, Exact Sciences Corp (EXAS) stock could reach $49.10 by 2030, $2.5756 by 2040 and $63.74 by 2050. See the projected annual prices until 2050 of the Exact Sciences Corp stock below:
- Exact Sciences Corp (EXAS) is expected to reach an average price of $21.39 in 2035, with a high prediction of $24.66 and a low estimate of $13.62. This indicates an $-79.28% rise from the last recorded price of $103.23.
- Exact Sciences Corp (EXAS) stock is projected to chart a bullish course in 2040, with an average price target of $6.8394, representing an $-93.37% surge from its current level. The forecast ranges from a conservative $6.5156 to a sky-high $2.5756.
- Our analysts predict Exact Sciences Corp (EXAS) to jump -36.14% by 2045, soaring from $61.56 to an average price of $65.92, potentially reaching $65.24. While $61.56 is the low estimate, the potential upside is significant.
- Exact Sciences Corp (EXAS) stock is expected to climb by 2050, reaching an average of $64.19, a $-37.81% jump from its current level. However, a wide range of estimates exists, with high and low targets of $63.74 and $55.43, respectively, highlighting the market's uncertainty.
Exact Sciences Corp Stock (EXAS) Year by Year Forecast
Exact Sciences Corp Stock (EXAS) Price Forecast for 2026
The predicted value for Exact Sciences Corp (EXAS) in 2026 is set at an average of $96.20. Estimates vary from a peak of $130.71 to a trough of $61.70, indicating an -6.81% surge from the present price of $103.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2026 | $117.06 | $93.61 | $123.77 | +13.40% |
| April, 2026 | $119.09 | $102.91 | $130.71 | +15.37% |
| May, 2026 | $105.10 | $81.48 | $117.87 | +1.81% |
| June, 2026 | $97.14 | $88.87 | $110.53 | -5.90% |
| July, 2026 | $68.54 | $61.70 | $111.90 | -33.61% |
| August, 2026 | $93.84 | $64.26 | $96.44 | -9.09% |
| September, 2026 | $91.85 | $84.71 | $106.06 | -11.02% |
| October, 2026 | $74.35 | $73.72 | $92.95 | -27.97% |
| November, 2026 | $76.85 | $62.04 | $78.90 | -25.56% |
| December, 2026 | $68.14 | $63.57 | $81.57 | -33.99% |
Exact Sciences Corp Stock (EXAS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Exact Sciences Corp (EXAS) is $43.55, with a high forecast of $77.40 and a low forecast of $9.6957. This indicates an -57.82% decrease from the last price of $103.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $66.91 | $63.64 | $74.07 | -35.18% |
| February, 2027 | $57.03 | $56.57 | $77.40 | -44.76% |
| March, 2027 | $53.44 | $46.55 | $63.41 | -48.23% |
| April, 2027 | $51.76 | $43.08 | $57.46 | -49.86% |
| May, 2027 | $51.21 | $40.21 | $57.83 | -50.39% |
| June, 2027 | $44.42 | $38.81 | $57.84 | -56.97% |
| July, 2027 | $43.76 | $30.54 | $49.15 | -57.61% |
| August, 2027 | $34.68 | $33.90 | $50.86 | -66.40% |
| September, 2027 | $28.03 | $20.27 | $38.16 | -72.85% |
| October, 2027 | $11.38 | $9.6957 | $27.89 | -88.98% |
| November, 2027 | $21.09 | $11.53 | $21.72 | -79.57% |
| December, 2027 | $17.42 | $16.78 | $24.58 | -83.13% |
Exact Sciences Corp Stock (EXAS) Price Forecast for 2028
In 2028, Exact Sciences Corp (EXAS) is projected to reach an average price of $40.05, with a high projection of $75.72 and a low estimate of $4.3737. This indicates an -61.20% fall from the last price of $103.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $10.96 | $9.0275 | $19.01 | -89.39% |
| February, 2028 | $7.515 | $6.645 | $17.17 | -92.72% |
| March, 2028 | $10.00 | $4.3737 | $11.69 | -90.31% |
| April, 2028 | $18.03 | $6.6912 | $23.56 | -82.53% |
| May, 2028 | $26.03 | $16.15 | $32.06 | -74.79% |
| June, 2028 | $43.96 | $21.54 | $45.96 | -57.41% |
| July, 2028 | $39.94 | $38.04 | $48.04 | -61.31% |
| August, 2028 | $38.08 | $35.45 | $45.54 | -63.11% |
| September, 2028 | $42.61 | $38.01 | $44.94 | -58.73% |
| October, 2028 | $43.70 | $37.71 | $45.31 | -57.66% |
| November, 2028 | $60.44 | $42.80 | $62.34 | -41.45% |
| December, 2028 | $70.66 | $59.54 | $75.72 | -31.55% |
Exact Sciences Corp Stock (EXAS) Price Forecast for 2029
The 2029 price forecast for Exact Sciences Corp Stock (EXAS) is $52.05 on average, with a high prediction of $77.65 and a low estimate of $26.46. This represents an -49.58% decrease from the previous price of $103.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $74.49 | $67.33 | $77.65 | -27.84% |
| February, 2029 | $57.57 | $56.52 | $73.96 | -44.23% |
| March, 2029 | $53.95 | $53.16 | $62.90 | -47.74% |
| April, 2029 | $42.70 | $39.43 | $53.85 | -58.64% |
| May, 2029 | $37.38 | $36.07 | $46.66 | -63.79% |
| June, 2029 | $44.81 | $36.09 | $46.96 | -56.59% |
| July, 2029 | $51.92 | $40.48 | $55.36 | -49.71% |
| August, 2029 | $43.54 | $41.11 | $54.58 | -57.83% |
| September, 2029 | $35.82 | $35.62 | $44.81 | -65.30% |
| October, 2029 | $40.59 | $34.38 | $43.71 | -60.68% |
| November, 2029 | $39.61 | $39.02 | $58.19 | -61.63% |
| December, 2029 | $27.24 | $26.46 | $43.69 | -73.61% |
Exact Sciences Corp Stock (EXAS) Price Forecast for 2030
Exact Sciences Corp Stock (EXAS) is expected to reach an average price of $30.63 in 2030, with a high forecast of $59.20 and a low forecast of $2.0607. This signifies an -70.33% decrease from the last price of $103.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $44.80 | $22.15 | $49.10 | -56.60% |
| February, 2030 | $50.17 | $44.39 | $57.02 | -51.40% |
| March, 2030 | $50.47 | $36.81 | $59.20 | -51.11% |
| April, 2030 | $54.91 | $42.57 | $58.63 | -46.81% |
| May, 2030 | $26.97 | $25.61 | $58.99 | -73.87% |
| June, 2030 | $27.05 | $22.43 | $36.24 | -73.79% |
| July, 2030 | $14.39 | $12.25 | $30.67 | -86.06% |
| August, 2030 | $34.01 | $15.19 | $34.75 | -67.05% |
| September, 2030 | $41.71 | $28.56 | $43.09 | -59.59% |
| October, 2030 | $36.17 | $23.44 | $36.55 | -64.96% |
| November, 2030 | $8.9706 | $2.0607 | $41.22 | -91.31% |
| December, 2030 | $5.4157 | $4.9414 | $6.7519 | -94.75% |
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):